Table 1.
First author [Ref.], year | Age, years | Sex | Diagnosis | Treatment | Followup | Recurrence | Adjuvant |
---|---|---|---|---|---|---|---|
Soudakoff, 1936a | 28 | M | Malignant nonteratoid | Enucleation | 13 mo | No | No |
Sayed [10], 1962 | 35 | F | Malignant nonteratoid | Enucleation | 6 mo | No | NR |
Zimmerman, 1972a | 32 | F | Malignant teratoid | Enucleation | NR | No | No |
Broughton [8], 1978a | 41 | NR | Benign | NR | NR | NR | NR |
Carrillo, 1979a | 43 | F | Malignant teratoid | Enucleation | 5 y | No | No |
Floyd, 1982a | 79 | M | Benign nonteratoid | Enucleation | NR | NR | No |
Litricin, 1985a | 50 | M | Malignant teratoid | Enucleation | NR | No | No |
Shields, 1996a | 58 | F | Malignant nonteratoid | Exenteration and RT | 2 y | Parotid metastasis | NR |
Husain, 1998a | 62 | M | Malignant nonteratoid | Neoadjuvant RT and enucleation | 6 mo | No | No |
Jumper, 1999a | 45 | M | Malignant | Exenteration and adjuvant RT | NR | NR | NR |
Davidorf, 2002a | 23 | F | Medulloepithelioma | BT and resection | 18 mo | No | No |
Font [11], 2005 | 27 | M | Malignant nonteratoid | Resection and enucleation | 6 y | No | No |
Sosinska-Mielcarek [9], 2006 | 44 | M | Malignant teratoid | Enucleation | 15 mo | Intracranial invasion | CT/RT |
Pushker [12], 2008 | 38 | F | Malignant non-teratoid | Enucleation | NR | NR | NR |
Meel [13], 2010 | 40 | M | Malignant non-teratoid | Enucleation | 6 mo | LN metastasis | CT/RT |
Singh [14], 2010 | 40 | M | Malignant non-teratoid | Enucleation | 7 mo | LN metastasis | CT/RT |
Ali [15], 2013 | 67 | F | Malignant non-teratoid | Enucleation | 5 y | No | No |
mo = Months; NR = not reported; y = years; RT = radiotherapy; BT = brachytherapy; CT = chemotherapy; LN = lymph node.
All referenced in Sosinska-Mielcarek et al. [9].